Searched for
FY27 REVENUE GROWTH
Doomsayers doomed, India bloomed: PM Modi after Q1 GDP growth quickens to 7.8% amid global tensionsIndia achieved a strong 7.8% GDP growth in the first quarter of FY27. Prime Minister Narendra Modi described this economic performance as a...01 Sep, 2026, 10.07 AM IST- Apr-July fiscal gap touches 26.8% of full-year targetThe Centre's fiscal deficit for April-July FY27 stood at 26.8 percent of the budget estimate. This figure showed a slight decrease compared...01 Sep, 2026, 01.15 AM IST
- Blackstone-backed Epsilon Bidco may sell 26% stake in EPL in Rs 1,985-crore block dealBlackstone-backed Epsilon Bidco plans to sell its 26.4% stake in packaging firm EPL Ltd through a block deal valued at approximately Rs 1,9...31 Aug, 2026, 09.19 PM IST
- Milky Mist Q1 Results: Profit zooms nearly 9 times YoY to Rs 65 crore; revenue rises 44%Milky Mist Dairy Food reported a nearly ninefold jump in Q1FY27 profit to Rs 65 crore, while revenue rose 43.6% year-on-year to Rs 973.45 c...31 Aug, 2026, 05.46 PM IST
- Nomura initiates coverage on Clean Max Enviro with Buy call. Check upside potential, key reasonsNomura initiated coverage on Clean Max Enviro Energy Solutions with a Buy rating and a Rs 1,510 target, implying 21% upside, citing strong ...31 Aug, 2026, 11.08 AM IST
- India's FY27 growth seen at 7-7.2% as capex, domestic demand offset global headwinds: EYIndia's real GDP growth is likely to remain resilient at 7 per cent-7.2 per cent in FY27, supported by buoyant domestic demand and continue...30 Aug, 2026, 02.50 PM IST
- Amrutanjan Health plans to set up 1 lakh direct chemist outlets in FY27Amrutanjan Health Care plans to establish one lakh direct chemist outlets this fiscal year. The company achieved strong growth in pain mana...30 Aug, 2026, 10.41 AM IST
- HSBC initiates coverage on this recently listed healthcare stock that can rally up to 26%. Do you own?HSBC has initiated coverage on recently listed Manipal Health with a Buy rating and Rs 1,000 target price, implying 26% upside. The brokera...28 Aug, 2026, 02.46 PM IST
- JM Financial calls Metropolis Healthcare ‘best-value diagnostic stock’, sees up to 27% upsideJM Financial has retained its Buy rating on Metropolis Healthcare with a target price of Rs 734, implying 27.2% upside. The brokerage calls...28 Aug, 2026, 01.32 PM IST
- Weddings, leisure and corporate comeback put India’s hotels on a stronger H2 path: ReportIndia's hotel sector anticipates stronger growth in the latter half of FY27. Robust domestic leisure demand and recovering corporate travel...28 Aug, 2026, 01.26 PM IST
- Can ESDS Software Solutions IPO deliver long-term growth for high-risk investors?In a bold move, ESDS Software Solutions is set to launch a ₹720 crore IPO to fuel its growth initiatives. The company excels in providing i...28 Aug, 2026, 06.50 AM IST
- India Inc revenue growth to moderate to 13-15 pc in Q2; margins to contract: ReportIndia Inc's revenue growth is projected to contract to fifteen percent in the September quarter. Operating profit margins are expected to c...27 Aug, 2026, 05.02 PM IST
- Motilal Oswal initiates coverage on Adani Enterprises with Buy, sees 25% upside. Here’s whyMotilal Oswal has initiated coverage on Adani Enterprises with a Buy rating and a target price of Rs 3,880, implying 25% upside from the pr...27 Aug, 2026, 11.40 AM IST
- Cyient shares rocket 8% after investor day, but brokerages see up to 24% downside. Here’s whyCyient shares jumped 8% after the IT services company outlined its growth and margin roadmap at its investor day. Management is targeting d...26 Aug, 2026, 11.23 AM IST
- Midcap IT likely to see better H2, AI-led deflation weighs on FY27 growth: Anand RathiIndia's midcap IT services sector could see improved deal conversion and operating leverage in the second half of FY27, but revenue growth ...24 Aug, 2026, 03.32 PM IST
- Growth broadens across India Inc: What an 8-quarter earnings review reveals about sectors, risks and returnsET Wealth presents an 8-quarter earnings assessment report of various sectors. The year-on-year net profit growth for 18 sectors is present...24 Aug, 2026, 11.10 AM IST
- Pharmeasy-parent’s loss narrows in Q1, revenue up 10%API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while reven...20 Aug, 2026, 07.29 PM IST
Load More
